Managing Cancer-Associated Thrombosis

You must be logged in to view this media.

Log in or Register


Managing Cancer-Associated Thrombosis

Broadcast Date
Agnes Lee, MD, MSc, FRCPC and Marc Carrier, MD, MSc, FRCPC
Therapeutic Area

Learning Objectives

  • Manage the transition from dual anti-platelet therapy at 12 months post-index event to long term antithrombotic management
  • Recognize the myth of the stable CAD patient by demonstrating the rate of recurrent event and mortality over 10 years
  • Define therapeutic options for two typical patient scenarios: 12 months post-PCI and chronic secondary prevention
  • Summarize different therapeutic options and targets for secondary prevention